BCH Lecture: Advances in diagnosing and staging prostate cancer 6/9/22

Prostate cancer hits one in nine men living in the U.S. and is the second leading cause of cancer death among American men. Yet when caught early, survival from prostate cancer is nearly 100 percent.

Hear board-certified urologists Drs. Carolyn Fronczak and Stephen Siegel describe the newest technologies that provide physicians with high-quality images, giving them the ability to find prostate cancer sooner. Then learn how prostate-specific membrane antigen (PSMA) is used for initial staging of intermediate-to-high risk cases, as well as restaging recurrent prostate cancer.

Click here to view/download a PDF of slides shown during this lecture.